We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

115 hedge funds and large institutions have $74M invested in Sanofi Contingent Value Rights in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less funds holding

Funds holding: 118 → 115 (-3)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

19% less capital invested

Capital invested by funds: $91.5M → $74M (-$17.4M)

22% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 18

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
3.07%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
7
Increased
14
Reduced
18
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EM
Elliott Management
New York
+$6.02M
2
OAM
Oxford Asset Management
United Kingdom
+$1.05M
3
CLOS
Compagnie Lombard Odier SCmA
Switzerland
+$699K
4
LCM
Lonestar Capital Management
California
+$365K
5
JP Morgan Chase
JP Morgan Chase
New York
+$34.8K

Top Sellers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
-$6.22M
2
WA
Whitebox Advisors
Minnesota
-$5.92M
3
PC
Pomelo Capital
New York
-$559K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$260K
5
Millennium Management
Millennium Management
New York
-$163K
Name Holding Trade Value Shares
Change 		Change in
Stake
HF
76
Hoxton Financial
West Virginia
$1K – – –
MWP
77
MYCIO Wealth Partners
Pennsylvania
$1K – – –
NEAM
78
New England Asset Management
Connecticut
$1K – – –
OC
79
Oakworth Capital
Alabama
$1K – – –
Royal Bank of Canada
80
Royal Bank of Canada
Ontario, Canada
$1K – – –
WT
81
Whittier Trust
California
$1K – – –
MFS
82
MSI Financial Services
Massachusetts
$1K +$466 +667 +232%
CP
83
Corbenic Partners
Pennsylvania
$1K +$562 +804 New
WEC
84
Winslow Evans & Crocker
Massachusetts
$934 – – –
SAM
85
Silverback Asset Management
North Carolina
$696 – – –
AIG
86
American International Group
New York
$531 +$78 +112 +17%
ACS
87
Archford Capital Strategies
Illinois
$461 – – –
CFA
88
CT Financial Advisors
Pennsylvania
$408 – – –
ECM
89
Estabrook Capital Management
New York
$9 – – –
MPWT
90
MassMutual Private Wealth & Trust
Connecticut
$9 – – –
Hudson Bay Capital Management
91
Hudson Bay Capital Management
Connecticut
– -$260K -329,400 Closed
SFM
92
Sphera Funds Management
Israel
– -$6.22M -67,960 Closed
AG
93
Aperio Group
California
– -$10K -13,069 Closed
UOC
94
University of Chicago
Illinois
– -$4K -10,303 Closed
KAM
95
Kassirer Asset Management
Ontario, Canada
– -$8K -10,000 Closed
TWA
96
TCI Wealth Advisors
Arizona
– -$2K -2,415 Closed
RC
97
RegentAtlantic Capital
New Jersey
– -$507 -642 Closed
TCOV
98
Trust Company of Vermont
Vermont
– -$105 -150 -27%
DADC
99
D.A. Davidson & Co
Montana
– -$45 -65 -7%
AIC
100
Ayalon Insurance Company
Israel
– +$5 +7 New
1 2 3
4
5

GCVRZ Hedge Fund Activity: Q1 2015 in Review

115 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q1 2015, worth a combined $74M — down 19% from $91.5M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of GCVRZ and 7 opened new positions — a net loss of 1 holder — while 18 trimmed existing stakes and 14 added.

The largest buyer was Elliott Management, opening a new position worth an estimated $6.02M. The largest seller was Sphera Funds Management, exiting entirely with an estimated $6.22M sold.

  • 115 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q1 2015, down from 118 in Q4 2014.
  • Funds reported $74M of Sanofi Contingent Value Rights stock for Q1 2015, down 19% quarter-over-quarter.
  • 7 funds opened new Sanofi Contingent Value Rights positions in Q1 2015 and 8 closed out, a net change of -1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q1 2015 was Elliott Management, an estimated $6.02M added.
  • The largest Sanofi Contingent Value Rights seller in Q1 2015 was Sphera Funds Management, an estimated $6.22M sold.

Based on aggregated 13F filings for Q1 2015.